drugset / Trial / NCT05945888
A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
RandomizedParallel-groupSingle-blindTreatment
Summary
The single rising dose (SRD) part of the trial investigates safety, tolerability, and pharmacokinetics of BI 3000202. The food effect (FE) part is conducted to assess the effect of food on the relative bioavailability of the BI 3000202 formulation.
Timeline
- Start
- 2023-07-25
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3000202 | Unknown | — | Oral |
Indications
No indication recorded.